Leadership Team 2016-2017

President
Eric Shi, Ph.D. Investigator, GSK, Waltham, MA

Chairman of the Board

Shiwen Lin, Ph.D. Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA

President-Elect (2017-2018)
Kevin Fang, Ph.D. Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA

Vice President 
Jian Shao, MBA, Founder and CEO, Sword Therapeutics

Bo Ying, Ph.D. Director, Formulation, PNA Innovations, Woburn, MA

Vice President of Finance
Zhendong Zhu, Ph.D. Principal Investigator, Celgene Avilomics Research, Bedford, MA

General Manager of Public Relations
Qingqing Cao, Ph.D. Sr Program manager, Insulet Corporation, Billerica, MA

General Manager of Operations
Ellen Fan, MSc., Ph.D. Candidate, Senior Scientist, Smith & Nephew, Andover, MA

Treasurer
Liping Zhou, Ph.D. Senior Scientist, Ipsen Biosciences., Cambridge, MA

Legal Counsel
Fred Gilman, Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA

Executive Committee Members

Lan Cao, Ph.D. Director, Unum Therapeutics, Cambridge, MA

Qinglin Che, Ph.D. Senior Scientist, Tetraphase Pharmaceuticals, Inc., Watertown, MA

Yin Chen, Ph.D. Director of Business Development at Accelagen

Shujia Daniel Dai, Ph.D. Principal Reserach Investigator, Sanofi-Aventis

Henry Gu, J.D. Intellectual Property Counsel, Agios Pharmaceuticals, Cambridge, MA

Jianfeng Jeff Hang, Ph.D. Director of Quality Systems, Makromed, Inc., Salem, NH

Jo Lee, M.Ec. Founder, Somebusiness, Inc.

Hao Howard Li, Ph.D. MBA, Cambridge Site Head, Novartis Knowledge Center, Novartis, Cambridge, MA

Jing Jeannie Li, Ph.D. Senior Scientist, Pfizer, Cambridge, MA

Carrie Liu, Ph.D. Associate Director of Technical Operation, Analytical, Vertex Pharmaceuticals, Boston, MA

Sue Ma, M.D. Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA

Xue Shui, Onkaido Therapeutics, a Moderna Venture

Yueming Wang, MBA Board Member and CEO of Zhonguan Pharmaceutical Co. Ltd., Beijing, China

Zhigang Wang, Ph.D. Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA

Li Xing, Ph. D.  Senior Director, Wuxi AppTec, Boston, MA

Wendy Yang, MBA, Manager, R&D Operational Planning and Capacity Management - CMC, Sanofi US, Waltham, MA

Chunxiao Yu, Ph.D. Postdoctoral Research Fellow, Harvard Medical School

Jingzhong Jeff Zhang, Ph.D. Senior Scientist, Medica Corp

Wei Zhang, Ph.D. Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA

Youxin Zhang, Ph.D. Managing Consultant, Navigant Consulting, Boston, MA

Xiaoyong Zhao, Ph.D., Senior Scientist, Momenta

Board of Directors

Zhihong Chen, Ph.D. Past President (2011-2012)

Chaoyang Dai, Ph.D. Past president (2010-2011), President, Boston Biosolutions

Jun Han, Ph.D. Founding President, CEO, SOTA International LLC, Boston, MA

Susan Qu, Ph.D. MBA Past president (2015-2016), External Manufacturing Integrated Risk Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA

Lixin Shen, Ph.D. President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China

Zhao-Kui (ZK) Wan, Ph.D. Past-President (2009-2010), Head of Chemistry and a member of leadership team at Johnson & Johnson's Asian Pacific Discovery Center in Shanghai, China

Yihan Wang, Ph.D. President, Shenzhen TargetRx, Inc., Shenzhen, China

Erxi Wu, Ph.D. Director, Neuro-oncology Research Center, Baylor Scott & White Health; Associate Prof., Texas A&M University

Junjun Wu, Ph.D. Past President (2007-2009), CEO, WuXi AllNature Biotech LLC, Jiangsu, China

Xiang Yang Yu, Ph.D. Past president (2013-2014), Program Manager, Accellient Partners LLC, Waltham, MA

Zhiyong Yang, Ph.D. Past president (2014-2015), Senior Principal Scientist, Pfizer, Cambridge, MA

Philip Zhang, Ph. D., J. D. Past President (2012-2013), Co-Founder and Chairman, Milstein Zhang & Wu LLC, Newton, MA

CABA Advisors
Youssef Bennani, Ph.D. Site Head, Vertex Pharmaceuticals Inc.-Canada

Tim Clackson, Ph.D. President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Yuan-Hua Ding, Ph.D. Senior Director & Head of External R&D Innovation - Asia, Pfizer

Pierre Dodion, M.D., MBA, Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA

Chen Li, Ph.D. Chief Executive Officer, Hua Medicine, Inc., Shanghai, China

Luke Li, Ph.D. Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer

Shi Li, Ph.D. CEO, Zerun Biotechnology, Shanghai, CHINA

Yuanli Liu, Ph.D. Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health

Dawei Ma , Ph.D. Professor, Shanghai Institute of Organic Chemistry, Shanghai, China

Tarek Mansour, Ph.D. EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada

Tse Ping, Chairman, Sino Biopharmaceutical Ltd., Beijing, China

John Piwinski, Ph.D. Principal, JJPiwinski Pharma Consulting, LLC, New York, NY

Steve Projan, Ph.D. Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD

Tomi Sawyer, Ph.D. Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA

Liming Shao, Ph.D. Professor, Fudan University, Shanghai, China

Suvit Thaisrivongs, Ph.D. Vice President, Pfizer, Inc., Cambridge. MA

Roger Tung, Ph.D. CEO and President, Concert Pharmaceuticals, Lexington, MA

Yibin Xiang, Ph.D. CSO, Sanhome Pharma

Sunny Xie, Ph.D. Professor, Northeastern University

Gangfeng Xu, Ph.D. Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories

Steve Yang, Ph.D. Executive VP & COO, Wuxi Apptec

Howard Yuwen, Ph.D. Co-founder & VP Corporate Development & Regulatory Affairs, Genesun Pharmaceuticals

Zhaohui Sunny Zhou, Ph.D. Associate Professor, Department of Chemistry and Chemical Biology and Faculty Fellow, Barnett Institute of Chemical and BiologicalAnalysis, Northeastern University

CABA Thank the dedicated service from the retired EC members: Ze Tian and Jinbo Lee